{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:40:11Z","timestamp":1756122011712,"version":"3.44.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,25]]},"DOI":"10.7759\/cureus.90933","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:00:36Z","timestamp":1756119636000},"source":"Crossref","is-referenced-by-count":0,"title":["An Autopsy Case of Neurofibromatosis Type 1 Mutation Detected in a Duodenal Lesion of Malignant Melanoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Mai","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Saitou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Fujihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsunari","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000912","article-title":"Melanocytic neoplasms in neurofibromatosis type 1: a systematic review","volume":"33","author":"Meyer SN","year":"2023","unstructured":"Meyer SN, Simmons E, Studer AC, Rauen KA, Kiuru M. Melanocytic neoplasms in neurofibromatosis type 1: a systematic review. Melanoma Res. 2023, 33:437-46. 10.1097\/CMR.0000000000000912","journal-title":"Melanoma Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.145","article-title":"Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?","volume":"23","author":"Pasmant E","year":"2015","unstructured":"Pasmant E, Parfait B, Luscan A, et al.. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?. Eur J Hum Genet. 2015, 23:596-601. 10.1038\/ejhg.2014.145","journal-title":"Eur J Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115850","article-title":"Current understanding of neurofibromatosis type 1, 2, and schwannomatosis","volume":"22","author":"Tamura R","year":"2021","unstructured":"Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021, 22:14-6. 10.3390\/ijms22115850","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans DG","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010, 152A:327-32. 10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1159\/000126545","article-title":"NF1 mutational spectrum","volume":"16","author":"Messiaen L","year":"2008","unstructured":"Messiaen L, Wimmer K. NF1 mutational spectrum. Monogr Hum Genet. 2008, 16:63-5.","journal-title":"Monogr Hum Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.9.1311","article-title":"Status of the NF1 tumor suppressor locus in uveal melanoma","volume":"121","author":"Foster WJ","year":"2003","unstructured":"Foster WJ, Fuller CE, Perry A, Harbour JW. Status of the NF1 tumor suppressor locus in uveal melanoma. Arch Ophthalmol. 2003, 121:1311-5. 10.1001\/archopht.121.9.1311","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/genes14091668","article-title":"Genetic aspects of conjunctival melanoma: a review","volume":"14","author":"Chang E","year":"2023","unstructured":"Chang E, Demirci H, Demirci FY. Genetic aspects of conjunctival melanoma: a review. Genes (Basel). 2023, 14:26-8. 10.3390\/genes14091668","journal-title":"Genes (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602598","article-title":"Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS","volume":"92","author":"Zuidervaart W","year":"2005","unstructured":"Zuidervaart W, van Nieuwpoort F, Stark M, et al.. Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer. 2005, 92:2032-8. 10.1038\/sj.bjc.6602598","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma. Cell. 2015, 161:1681-96. 10.1016\/j.cell.2015.05.044","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(00)00154-5","article-title":"Iris melanoma in a patient with neurofibromatosis","volume":"45","author":"Honavar SG","year":"2000","unstructured":"Honavar SG, Singh AD, Shields CL, Shields JA, Eagle RC Jr. Iris melanoma in a patient with neurofibromatosis. Surv Ophthalmol. 2000, 45:231-6. 10.1016\/s0039-6257(00)00154-5","journal-title":"Surv Ophthalmol"},{"key":"ref11","article-title":"Recent knowledge about cancer metastasis. Cancer metastasis as observed in autopsy records","volume":"15","author":"Urano Y","year":"1985","unstructured":"Urano Y, Fukushima T, Kitamura S, Mori H, Baba K, Aizawa S. Recent knowledge about cancer metastasis. Cancer metastasis as observed in autopsy records. Oncologia. 1985, 15:46-71.","journal-title":"Oncologia"},{"key":"ref12","article-title":"The Spread of Tumors in the Human Body","author":"Willis RA","year":"1952","unstructured":"Willis RA. The Spread of Tumors in the Human Body. Butterworth, London, UK; 1952."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.129.4.605","article-title":"Radiologic spectrum of melanoma metastatic to the gastrointestinal tract","volume":"129","author":"Goldstein HM","year":"1977","unstructured":"Goldstein HM, Beydoun MT, Dodd GD. Radiologic spectrum of melanoma metastatic to the gastrointestinal tract. AJR Am J Roentgenol. 1977, 129:605-12. 10.2214\/ajr.129.4.605","journal-title":"AJR Am J Roentgenol"},{"key":"ref14","article-title":"Metastases to the gastrointestinal tract from malignant melanoma","volume":"88","author":"Pomerantz H","year":"1962","unstructured":"Pomerantz H, Margolin HN. Metastases to the gastrointestinal tract from malignant melanoma. Am J Roentgenol Radium Ther Nucl Med. 1962, 88:712-7.","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1098235","article-title":"Gastrointestinal metastasis of a malignant melanoma","volume":"5","author":"Meyer-Burg J","year":"1973","unstructured":"Meyer-Burg J, Treichel J, Ziegler U. Gastrointestinal metastasis of a malignant melanoma. Endoscopy. 1973, 5:160161. 10.1055\/s-0028-1098235","journal-title":"Endoscopy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.11280\/gee1973b.36.1597","article-title":"A late recurrence case of chorioidal malignant melanoma with metastatic lesion in the stomach and the liver on 13 years after surgery","volume":"36","author":"Fukuda T","year":"1994","unstructured":"Fukuda T, Shinohara M, Orino S, Saijo T, ITO-Kunio S. A late recurrence case of chorioidal malignant melanoma with metastatic lesion in the stomach and the liver on 13 years after surgery. Gastroenterol Endosc. 1994, 36:1597-605. 10.11280\/gee1973b.36.1597","journal-title":"Gastroenterol Endosc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.11280\/gee1973b.29.1806","article-title":"A case of metastatic malignant melanoma of the liver confirmed laparoscopically 11 years after enucleation of malignant melanoma of the right eye","volume":"29","author":"Yamada T","year":"1987","unstructured":"Yamada T, Ohta W, Iwamura K. A case of metastatic malignant melanoma of the liver confirmed laparoscopically 11 years after enucleation of malignant melanoma of the right eye. Gastroenterol Endosc. 1987, 29:1806-11. 10.11280\/gee1973b.29.1806","journal-title":"Gastroenterol Endosc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1021746","article-title":"Laparoscopy in the diagnosis of liver metastases in 80 cases of malignant melanoma","volume":"12","author":"Bleiberg H","year":"1980","unstructured":"Bleiberg H, La Meir E, Lejeune F. Laparoscopy in the diagnosis of liver metastases in 80 cases of malignant melanoma. Endoscopy. 1980, 12:215-8. 10.1055\/s-2007-1021746","journal-title":"Endoscopy"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037138","article-title":"Duodenal malignant melanoma: primary and metastatic case series and literature review","volume":"103","author":"Zhou B","year":"2024","unstructured":"Zhou B, Li X, Liu J, Peng L, Liu X. Duodenal malignant melanoma: primary and metastatic case series and literature review. Medicine (Baltimore). 2024, 103:e37138. 10.1097\/MD.0000000000037138","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2015.048","article-title":"Duodenal and gallbladder metastasis of regressive melanoma: a case report and review of the literature","volume":"6","author":"Ettahri H","year":"2015","unstructured":"Ettahri H, Elomrani F, Elkabous M, Rimani M, Boutayeb S, Mrabti H, Errihani H. Duodenal and gallbladder metastasis of regressive melanoma: a case report and review of the literature. J Gastrointest Oncol. 2015, 6:E77-81. 10.3978\/j.issn.2078-6891.2015.048","journal-title":"J Gastrointest Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(09)70036-1","article-title":"Melanoma of the small intestine","volume":"10","author":"Lens M","year":"2009","unstructured":"Lens M, Bataille V, Krivokapic Z. Melanoma of the small intestine. Lancet Oncol. 2009, 10:516-21. 10.1016\/s1470-2045(09)70036-1","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2008.04.011","article-title":"Surgery for melanoma metastases of the gastrointestinal tract: indications and results","volume":"35","author":"Sanki A","year":"2009","unstructured":"Sanki A, Scolyer RA, Thompson JF. Surgery for melanoma metastases of the gastrointestinal tract: indications and results. Eur J Surg Oncol. 2009, 35:313-9. 10.1016\/j.ejso.2008.04.011","journal-title":"Eur J Surg Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.9.3.312","article-title":"Primary duodenal malignant melanoma: a case report","volume":"9","author":"Anvari K","year":"2018","unstructured":"Anvari K, Gharib M, Jafarian AH, Saburi A, Javadinia SA. Primary duodenal malignant melanoma: a case report. Caspian J Intern Med. 2018, 9:312-5. 10.22088\/cjim.9.3.312","journal-title":"Caspian J Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2022.0298","article-title":"Duodenal metastatic malignant melanoma","volume":"84","author":"Churchev S","year":"2023","unstructured":"Churchev S, Angelov T, Vladimirov B, Golemanov B. Duodenal metastatic malignant melanoma. Br J Hosp Med (Lond). 2023, 84:12-5. 10.12968\/hmed.2022.0298","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0879-9","article-title":"KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma","volume":"34","author":"Cicenas J","year":"2017","unstructured":"Cicenas J, Tamosaitis L, Kvederaviciute K, et al.. KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma. Med Oncol. 2017, 34:26. 10.1007\/s12032-016-0879-9","journal-title":"Med Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4254","article-title":"A mouse model of melanoma driven by oncogenic KRAS","volume":"70","author":"Milagre C","year":"2010","unstructured":"Milagre C, Dhomen N, Geyer FC, Hayward R, Lambros M, Reis-Filho JS, Marais R. A mouse model of melanoma driven by oncogenic KRAS. Cancer Res. 2010, 70:5549-57. 10.1158\/0008-5472.CAN-09-4254","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems H","year":"2007","unstructured":"Brems H, Chmara M, Sahbatou M, et al.. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007, 39:1120-6. 10.1038\/ng2113","journal-title":"Nat Genet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10480-z","article-title":"Assessment of ecotropic viral integration site 2B (EVI2B) gene in juvenile myelomonocytic leukemia and neurofibromatosis type 1 NF1 tumors","volume":"62","author":"Saharafi P","year":"2024","unstructured":"Saharafi P, Akar \u0130, Ersoy-Evans S, et al.. Assessment of ecotropic viral integration site 2B (EVI2B) gene in juvenile myelomonocytic leukemia and neurofibromatosis type 1 NF1 tumors. Biochem Genet. 2024, 62:1263-76. 10.1007\/s10528-023-10480-z","journal-title":"Biochem Genet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pbr.2018.09.014","article-title":"Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms","volume":"241","author":"Molosh AI","year":"2018","unstructured":"Molosh AI, Shekhar A. Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms. Prog Brain Res. 2018, 241:37-62. 10.1016\/bs.pbr.2018.09.014","journal-title":"Prog Brain Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-020-04717-0","article-title":"Clinical characterization of children and adolescents with NF1 microdeletions","volume":"36","author":"Kehrer-Sawatzki H","year":"2020","unstructured":"Kehrer-Sawatzki H, Kluwe L, Salamon J, Well L, Farschtschi S, Rosenbaum T, Mautner VF. Clinical characterization of children and adolescents with NF1 microdeletions. Childs Nerv Syst. 2020, 36:2297-310. 10.1007\/s00381-020-04717-0","journal-title":"Childs Nerv Syst"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0069","article-title":"The use of MEK inhibitors in neurofibromatosis type 1-associated tumors and management of toxicities","volume":"25","author":"Klesse LJ","year":"2020","unstructured":"Klesse LJ, Jordan JT, Radtke HB, et al.. The use of MEK inhibitors in neurofibromatosis type 1-associated tumors and management of toxicities. Oncologist. 2020, 25:e1109-16. 10.1634\/theoncologist.2020-0069","journal-title":"Oncologist"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12316","article-title":"BRAF\/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib","volume":"28","author":"Ranzani M","year":"2015","unstructured":"Ranzani M, Alifrangis C, Perna D, et al.. BRAF\/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib. Pigment Cell Melanoma Res. 2015, 28:117-9. 10.1111\/pcmr.12316","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390696-an-autopsy-case-of-neurofibromatosis-type-1-mutation-detected-in-a-duodenal-lesion-of-malignant-melanoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:00:40Z","timestamp":1756119640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390696-an-autopsy-case-of-neurofibromatosis-type-1-mutation-detected-in-a-duodenal-lesion-of-malignant-melanoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.90933","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,25]]}}}